Who
In numbers
- Trades disclosed
- 80
- Buys
- 0
- Sells
- 22
- Bought
- $0
- Sold
- $1.8M
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 13 Oct 2009
- Last trade
- 20 Aug 2026
- Last filed
- 21 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 20 Aug 2026filed 21 Aug 2026 | OMER OmerosBiotechnology | SEC FORM 4 Code M | $15K7,500 at $2.00 | filing |
| 20 Aug 2026filed 21 Aug 2026 | OMER OmerosBiotechnology | SEC FORM 4 Code M | $29K7,500 at $3.93 | filing |
| 20 Aug 2026filed 21 Aug 2026 | OMER OmerosBiotechnology | SEC FORM 4 Sold | $277K15,000 at $18.45 | filing |
| 20 Aug 2026filed 21 Aug 2026 | OMER Omerosoption or derivative · Biotechnology | SEC FORM 4 Code M | —7,500 at $0.00 | filing |
| 20 Aug 2026filed 21 Aug 2026 | OMER Omerosoption or derivative · Biotechnology | SEC FORM 4 Code M | —7,500 at $0.00 | filing |
| 20 Aug 2026filed 21 Aug 2026 | OMER Omerosoption or derivative · Biotechnology | SEC FORM 4 Code M | —7,500 at $0.00 | filing |
| 20 Aug 2026filed 21 Aug 2026 | OMER Omerosoption or derivative · Biotechnology | SEC FORM 4 Code M | —7,500 at $0.00 | filing |
| 20 Aug 2026filed 21 Aug 2026 | OMER OmerosBiotechnology | SEC FORM 4 Code M | $15K7,500 at $2.00 | filing |
| 20 Aug 2026filed 21 Aug 2026 | OMER OmerosBiotechnology | SEC FORM 4 Code M | $29K7,500 at $3.93 | filing |
| 20 Aug 2026filed 21 Aug 2026 | OMER OmerosBiotechnology | SEC FORM 4 Sold | $277K15,000 at $18.45 | filing |
| 18 Jun 2026filed 22 Jun 2026 | OMER Omerosoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 18 Jun 2026filed 22 Jun 2026 | OMER Omerosoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 22 May 2026filed 27 May 2026 | OMER OmerosBiotechnology | SEC FORM 4 Code M | $81K7,500 at $10.84 | filing |
| 22 May 2026filed 27 May 2026 | OMER OmerosBiotechnology | SEC FORM 4 Sold | $87K7,500 at $11.61 | filing |
| 22 May 2026filed 27 May 2026 | OMER Omerosoption or derivative · Biotechnology | SEC FORM 4 Code M | —7,500 at $0.00 | filing |
| 22 May 2026filed 27 May 2026 | OMER Omerosoption or derivative · Biotechnology | SEC FORM 4 Code M | —7,500 at $0.00 | filing |
| 22 May 2026filed 27 May 2026 | OMER OmerosBiotechnology | SEC FORM 4 Code M | $81K7,500 at $10.84 | filing |
| 22 May 2026filed 27 May 2026 | OMER OmerosBiotechnology | SEC FORM 4 Sold | $87K7,500 at $11.61 | filing |
| 27 Jun 2025filed 1 Jul 2025 | OMER Omerosoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 6 Jun 2024filed 7 Jun 2024 | OMER Omerosoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
News
Omeros Stock Falls 12% After EMA Committee Reaffirms Negative Narsoplimab OpinionOMER · rttnews.com · 16 Oct 2026Omeros Receives Second CHMP Rejection For Narsoplimab In Europe; Stock DownOMER · rttnews.com · 16 Oct 2026Omeros Corporation Receives CHMP Negative Opinion Following Re-Examination of European Marketing Authorization Application for Narsoplimab in TA-TMAOMER · finanznachrichten.de · 16 Oct 2026
0 headlines in the last 90 days name Thomas J. Cable; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.